Citazione APA

Pirzada, R. H., Haseeb, M., Batool, M., Kim, M., & Choi, S. (2021). Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication. Cells.

Stile di citazione Chicago

Pirzada, Rameez Hassan, Muhammad Haseeb, Maria Batool, MoonSuk Kim, e Sangdun Choi. "Remdesivir and Ledipasvir Among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication." Cells 2021.

Citazione MLA

Pirzada, Rameez Hassan, et al. "Remdesivir and Ledipasvir Among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication." Cells 2021.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.